AJEM: Rapid antigen test is used to identify whether patients with new coronary pneumonia admitted to the emergency department have symptoms

Purpose: Since the beginning of the SARS-CoV-2 pandemic, the rapid identification and isolation of infected patients has proven to be a key factor in limiting the spread of the virus and containing the pandemic

Method: From July 1, 2020 to December 10, 2020, all patients who were continuously evaluated as suspected of new coronary pneumonia symptoms in the emergency room or who needed to be hospitalized because they were not related to new coronary pneumonia received rapid antigen testing and RT-PCR Swab test

Results: A total of 3899 patients were tested for antigen and PCR swabs

Table 1 A 2 × 2 contingency table for evaluating the patient's rapid antigen test performance in all COVID-19 patients

Table 2 Demographic and baseline characteristics of patients evaluated in the emergency department with suspicious symptoms of SARS-CoV-2

Table 3 Two 2 × 2 contingency tables for the performance evaluation of rapid antigen detection in COVID-19 patients

Figure 1 A) Decision curve analysis and its distribution

Turcato G, Zaboli A, Pfeifer N,et al.